Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2022 366069.1% Revenue growth, 20223 Where the money goes Where each dollar of revenue went, fiscal 2022 Cost of revenue Other costs
Cost of revenue 24¢ $70.8K Other costs 76¢ $225.8K Out of $296.6K in revenue.3
Financial statements
Income statement Balance sheet Cash flow
Annual Quarterly
Revenue4 5 6 3 $296.6K in 2022+2418% since 2018 0 $100.0K $200.0K $300.0K 2018: $11.8K $11.8K 2018 2019: $17.9K $17.9K 2019 +52% 2020: $222 $222 2020 −99% 2021: $81 $81 2021 −64% 2022: $296.6K $296.6K 2022 +366069% Gross profit4 5 6 3 $225.8K in 2022+2963% since 2018 0 $100.0K $200.0K $300.0K 2018: $7.4K $7.4K 2018 2019: $12.0K $12.0K 2019 +63% 2020: $186 $186 2020 −98% 2021: $81 $81 2021 −56% 2022: $225.8K $225.8K 2022 +278681% Operating income4 5 6 3 -$340.9K in 2022+791% since 2018 -$400.0K -$300.0K -$200.0K -$100.0K 0 2018: -$38.3K -$38.3K 2018 2019: -$22.7K -$22.7K 2019 −41% 2020: -$64.7K -$64.7K 2020 +185% 2021: -$45.8K -$45.8K 2021 −29% 2022: -$340.9K -$340.9K 2022 +644% Net income4 5 6 3 -$342.6K in 2022+798% since 2018 -$400.0K -$300.0K -$200.0K -$100.0K 0 2018: -$38.2K -$38.2K 2018 2019: -$22.6K -$22.6K 2019 −41% 2020: -$64.6K -$64.6K 2020 +186% 2021: -$45.8K -$45.8K 2021 −29% 2022: -$342.6K -$342.6K 2022 +648% Revenue7 8 $16.3K in Q3 FY2023−31% since Q2 FY2023 0 $10.0K $20.0K $30.0K Q2 FY2023: $23.5K $23.5K Q2 FY2023 Q3 FY2023: $16.3K $16.3K Q3 FY2023 −31% Gross profit7 8 $10.2K in Q3 FY2023−45% since Q2 FY2023 0 $5.0K $10.0K $15.0K $20.0K Q2 FY2023: $18.7K $18.7K Q2 FY2023 Q3 FY2023: $10.2K $10.2K Q3 FY2023 −45% Operating income7 8 -$402.9K in Q3 FY2023−61% since Q2 FY2023 -$1.5M -$1.0M -$500.0K 0 Q2 FY2023: -$1.0M -$1.0M Q2 FY2023 Q3 FY2023: -$402.9K -$402.9K Q3 FY2023 −61% Net income7 8 -$415.1K in Q3 FY2023+588% since Q2 FY2023 -$1.5M -$1.0M -$500.0K 0 Q2 FY2023: -$60.3K -$60.3K Q2 FY2023 Q3 FY2023: -$60.3K -$60.3K Q3 FY2023 +0% Q2 FY2023: -$1.0M -$1.0M Q2 FY2023 +1615% Q3 FY2023: -$1.0M -$1.0M Q3 FY2023 +0% Q3 FY2023: -$415.1K -$415.1K Q3 FY2023 −60% Fiscal year 2017 2018 2019 2020 2021 2022 Revenue $11.8K4 $17.9K5 $2226 $813 $296.6K3 Cost of revenue $4.4K4 $5.9K5 $366 $70.8K3 Gross profit $7.4K4 $12.0K5 $1866 $813 $225.8K3 Research and development $6494 Operating income -$38.3K4 -$22.7K5 -$64.7K6 -$45.8K3 -$340.9K3 Net income -$38.2K4 -$22.6K5 -$64.6K6 -$45.8K3 -$342.6K3
Total assets4 5 6 3 $680.7K in 2022+3961% since 2017 0 $200.0K $400.0K $600.0K $800.0K 2017: $16.8K $16.8K 2017 2018: $64.3K $64.3K 2018 +284% 2019: $53.8K $53.8K 2019 −16% 2020: $13.6K $13.6K 2020 −75% 2021: $9.5K $9.5K 2021 −30% 2022: $680.7K $680.7K 2022 +7066% Total liabilities4 5 6 3 $1.1M in 2022+4318% since 2017 0 $500.0K $1.0M $1.5M 2017: $25.9K $25.9K 2017 2018: $65.0K $65.0K 2018 +151% 2019: $77.1K $77.1K 2019 +19% 2020: $101.5K $101.5K 2020 +32% 2021: $143.2K $143.2K 2021 +41% 2022: $1.1M $1.1M 2022 +699% Shareholders’ equity4 5 6 3 -$463.3K in 2022+4974% since 2017 -$600.0K -$400.0K -$200.0K 0 2017: -$9.1K -$9.1K 2017 2018: -$693 -$693 2018 −92% 2019: -$23.2K -$23.2K 2019 +3255% 2020: -$87.9K -$87.9K 2020 +278% 2021: -$133.7K -$133.7K 2021 +52% 2022: -$463.3K -$463.3K 2022 +247% Cash4 5 6 3 $41.8K in 2022+149% since 2017 0 $20.0K $40.0K $60.0K 2017: $16.8K $16.8K 2017 2018: $36.6K $36.6K 2018 +118% 2019: $19.9K $19.9K 2019 −46% 2020: $13.6K $13.6K 2020 −32% 2021: $9.5K $9.5K 2021 −30% 2022: $41.8K $41.8K 2022 +340% Total assets7 8 $884.0K in Q3 FY2023−33% since Q2 FY2023 0 $500.0K $1.0M $1.5M Q2 FY2023: $1.3M $1.3M Q2 FY2023 Q3 FY2023: $884.0K $884.0K Q3 FY2023 −33% Total liabilities7 8 $328.1K in Q3 FY2023+6% since Q2 FY2023 0 $100.0K $200.0K $300.0K $400.0K Q2 FY2023: $310.3K $310.3K Q2 FY2023 Q3 FY2023: $328.1K $328.1K Q3 FY2023 +6% Shareholders’ equity7 8 $555.9K in Q3 FY2023+1094% since Q2 FY2023 0 $500.0K $1.0M $1.5M Q2 FY2023: $46.5K $46.5K Q2 FY2023 Q3 FY2023: $46.5K $46.5K Q3 FY2023 +0% Q2 FY2023: $1.0M $1.0M Q2 FY2023 +2076% Q3 FY2023: $1.0M $1.0M Q3 FY2023 +0% Q3 FY2023: $555.9K $555.9K Q3 FY2023 −45% Cash7 8 $10.6K in Q3 FY2023−2% since Q2 FY2023 0 $5.0K $10.0K $15.0K Q2 FY2023: $10.8K $10.8K Q2 FY2023 Q3 FY2023: $10.6K $10.6K Q3 FY2023 −2% Fiscal year 2017 2018 2019 2020 2021 2022 Cash $16.8K4 $36.6K5 $19.9K6 $13.6K6 $9.5K6 $41.8K3 Current assets $16.8K4 $64.3K4 $53.8K5 $13.6K6 $9.5K3 $79.6K3 Total assets $16.8K4 $64.3K4 $53.8K5 $13.6K6 $9.5K3 $680.7K3 Current liabilities $25.9K4 $65.0K4 $77.1K5 $101.5K6 $143.2K3 $1.1M3 Total liabilities $25.9K4 $65.0K4 $77.1K5 $101.5K6 $143.2K3 $1.1M3 Shareholders’ equity -$9.1K4 -$6935 -$23.2K6 -$87.9K3 -$133.7K3 -$463.3K3 Shares outstanding 3.0M shares4 23.9M shares4 23.9M shares5 23.9M shares6 23.9M shares3 75.0M shares3
Cash from operations4 5 6 3 -$199.2K in 2022+236% since 2018 -$200.0K -$150.0K -$100.0K -$50.0K 0 2018: -$59.4K -$59.4K 2018 2019: -$31.9K -$31.9K 2019 −46% 2020: -$38.0K -$38.0K 2020 +19% 2021: -$45.8K -$45.8K 2021 +20% 2022: -$199.2K -$199.2K 2022 +335% Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Fiscal year 2017 2018 2019 2020 2021 2022 Cash from operations -$59.4K4 -$31.9K5 -$38.0K6 -$45.8K3 -$199.2K3
Compare Adorbs Inc with another company
Former names
Soul Biotechnology Corp Mar 13, 2023 to Oct 27, 20232 Adorbs Inc. Jan 19, 2018 to Oct 21, 20222
Recent filings
Nov 20, 2023 10-Q Oct 27, 2023 8-K Sep 27, 2023 10-Q Aug 7, 2023 S-1 May 15, 2023 10-Q Mar 13, 2023 10-K Mar 13, 2023 8-K Oct 21, 2022 10-Q Aug 1, 2022 10-Q May 10, 2022 10-Q May 5, 2022 8-K Feb 10, 2022 8-K Feb 8, 2022 10-K Dec 9, 2021 10-K/A Every filing from the last three years, summarized . The full record is on SEC EDGAR.1
